CI Private Wealth »

Arrivent Biopharma shares owned by CI Private Wealth

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $608k 27k 22.31
2025-09-30 $618k 34k 18.45

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Johnson & Johnson (JNJ)

View all positions for CI Private Wealth

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group

View all funds holding Arrivent Biopharma